Nobivac Canine 1-DAPPv+L4

Nobivac Canine 1-DAPPv+L4 A multi-purpose 1-year vaccine that has two critical indications in the protection against leptospirosis and also protects against all strains of canine parvovirus (CPV). Protects against all known strains of CPV, including CPV-2c1-3. Contains CPV-2b, one of the most prevalent field strains of parvovirus. High antigenic mass (titer), low passage parvovirus vaccine. Overrides maternal antibodies in young puppies. The only leptospirosis vaccine to protect and defend against mortality and urinary shedding. Prevented mortality caused by four virulent Leptospira serovars. Protects against two types of adenovirus that cause hepatitis and respiratory disease in dogs. Provides disease coverage for commonly spread canine viruses, distemper, and parainfluenza, in one formula Approved for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus types 1 and 2, parainfluenza, and parvovirus. Indicated as an aid in the revention of disease and mortality caused by L. canicola, L. icterohaemorrhagiae, L. pomona, or L. grippotyphosa. Prevents leptospiruria associated with L. grippotyphosa, L. canicola, or L. icterohaemorrhagiae. Aids in the prevention of leptospiruria associated with L. pomona. Recommended for use in healthy dogs 8 weeks of age or older.